262 related articles for article (PubMed ID: 20661612)
1. Identification of novel SNPs of ABCD1, ABCD2, ABCD3, and ABCD4 genes in patients with X-linked adrenoleukodystrophy (ALD) based on comprehensive resequencing and association studies with ALD phenotypes.
Matsukawa T; Asheuer M; Takahashi Y; Goto J; Suzuki Y; Shimozawa N; Takano H; Onodera O; Nishizawa M; Aubourg P; Tsuji S
Neurogenetics; 2011 Feb; 12(1):41-50. PubMed ID: 20661612
[TBL] [Abstract][Full Text] [Related]
2. X-linked adrenoleukodystrophy phenotype is independent of ABCD2 genotype.
Maier EM; Mayerhofer PU; Asheuer M; Köhler W; Rothe M; Muntau AC; Roscher AA; Holzinger A; Aubourg P; Berger J
Biochem Biophys Res Commun; 2008 Dec; 377(1):176-80. PubMed ID: 18834860
[TBL] [Abstract][Full Text] [Related]
3. Decreased expression of ABCD4 and BG1 genes early in the pathogenesis of X-linked adrenoleukodystrophy.
Asheuer M; Bieche I; Laurendeau I; Moser A; Hainque B; Vidaud M; Aubourg P
Hum Mol Genet; 2005 May; 14(10):1293-303. PubMed ID: 15800013
[TBL] [Abstract][Full Text] [Related]
4. Eight novel mutations in the ABCD1 gene and clinical characteristics of 25 Chinese patients with X-linked adrenoleukodystrophy.
Chu SS; Ye J; Zhang HW; Han LS; Qiu WJ; Gao XL; Gu XF
World J Pediatr; 2015 Nov; 11(4):366-73. PubMed ID: 26454440
[TBL] [Abstract][Full Text] [Related]
5. ABCD1 mutations and phenotype distribution in Chinese patients with X-linked adrenoleukodystrophy.
Niu YF; Ni W; Wu ZY
Gene; 2013 Jun; 522(1):117-20. PubMed ID: 23566833
[TBL] [Abstract][Full Text] [Related]
6. Metformin-induced mitochondrial function and ABCD2 up-regulation in X-linked adrenoleukodystrophy involves AMP-activated protein kinase.
Singh J; Olle B; Suhail H; Felicella MM; Giri S
J Neurochem; 2016 Jul; 138(1):86-100. PubMed ID: 26849413
[TBL] [Abstract][Full Text] [Related]
7. Fibrate induction of the adrenoleukodystrophy-related gene (ABCD2): promoter analysis and role of the peroxisome proliferator-activated receptor PPARalpha.
Fourcade S; Savary S; Albet S; Gauthé D; Gondcaille C; Pineau T; Bellenger J; Bentejac M; Holzinger A; Berger J; Bugaut M
Eur J Biochem; 2001 Jun; 268(12):3490-500. PubMed ID: 11422379
[TBL] [Abstract][Full Text] [Related]
8. Investigating ABCD1 mutations in a Taiwanese cohort with hereditary spastic paraplegia phenotype.
Hsu SL; Chen YH; Chou CT; Chou YT; Tsai YS; Hsiao CT; Liao YC; Lee YC
Parkinsonism Relat Disord; 2021 Nov; 92():7-12. PubMed ID: 34649108
[TBL] [Abstract][Full Text] [Related]
9. Targeted Brain Delivery of Dendrimer-4-Phenylbutyrate Ameliorates Neurological Deficits in a Long-Term ABCD1-Deficient Mouse Model of X-Linked Adrenoleukodystrophy.
Nemeth CL; Gӧk Ö; Tomlinson SN; Sharma A; Moser AB; Kannan S; Kannan RM; Fatemi A
Neurotherapeutics; 2023 Jan; 20(1):272-283. PubMed ID: 36207570
[TBL] [Abstract][Full Text] [Related]
10. A novel mutation in the ABCD1 gene of a Korean boy diagnosed with X-linked adrenoleukodystrophy.
Park JA; Jun KR; Han SH; Kim GH; Yoo HW; Hur YJ
Gene; 2012 Apr; 498(1):131-3. PubMed ID: 22326269
[TBL] [Abstract][Full Text] [Related]
11. Genomic profiling identifies novel mutations and SNPs in ABCD1 gene: a molecular, biochemical and clinical analysis of X-ALD cases in India.
Kumar N; Taneja KK; Kalra V; Behari M; Aneja S; Bansal SK
PLoS One; 2011; 6(9):e25094. PubMed ID: 21966424
[TBL] [Abstract][Full Text] [Related]
12. X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism is severely impaired in monocytes but not in lymphocytes.
Weber FD; Wiesinger C; Forss-Petter S; Regelsberger G; Einwich A; Weber WH; Köhler W; Stockinger H; Berger J
Hum Mol Genet; 2014 May; 23(10):2542-50. PubMed ID: 24363066
[TBL] [Abstract][Full Text] [Related]
13. Impaired very long-chain acyl-CoA β-oxidation in human X-linked adrenoleukodystrophy fibroblasts is a direct consequence of ABCD1 transporter dysfunction.
Wiesinger C; Kunze M; Regelsberger G; Forss-Petter S; Berger J
J Biol Chem; 2013 Jun; 288(26):19269-79. PubMed ID: 23671276
[TBL] [Abstract][Full Text] [Related]
14. ABCD1 translation-initiator mutation demonstrates genotype-phenotype correlation for AMN.
O'Neill GN; Aoki M; Brown RH
Neurology; 2001 Dec; 57(11):1956-62. PubMed ID: 11739809
[TBL] [Abstract][Full Text] [Related]
15. ABCD1 gene mutations in Chinese patients with X-linked adrenoleukodystrophy.
Pan H; Xiong H; Wu Y; Zhang YH; Bao XH; Jiang YW; Wu XR
Pediatr Neurol; 2005 Aug; 33(2):114-20. PubMed ID: 16087056
[TBL] [Abstract][Full Text] [Related]
16. Caffeic acid phenethyl ester induces adrenoleukodystrophy (Abcd2) gene in human X-ALD fibroblasts and inhibits the proinflammatory response in Abcd1/2 silenced mouse primary astrocytes.
Singh J; Khan M; Singh I
Biochim Biophys Acta; 2013 Apr; 1831(4):747-58. PubMed ID: 23318275
[TBL] [Abstract][Full Text] [Related]
17. ABCD2 is a direct target of β-catenin and TCF-4: implications for X-linked adrenoleukodystrophy therapy.
Park CY; Kim HS; Jang J; Lee H; Lee JS; Yoo JE; Lee DR; Kim DW
PLoS One; 2013; 8(2):e56242. PubMed ID: 23437103
[TBL] [Abstract][Full Text] [Related]
18. ABCD1 mutations and the X-linked adrenoleukodystrophy mutation database: role in diagnosis and clinical correlations.
Kemp S; Pujol A; Waterham HR; van Geel BM; Boehm CD; Raymond GV; Cutting GR; Wanders RJ; Moser HW
Hum Mutat; 2001 Dec; 18(6):499-515. PubMed ID: 11748843
[TBL] [Abstract][Full Text] [Related]
19. Cholesterol regulates ABCD2 expression: implications for the therapy of X-linked adrenoleukodystrophy.
Weinhofer I; Forss-Petter S; Zigman M; Berger J
Hum Mol Genet; 2002 Oct; 11(22):2701-8. PubMed ID: 12374760
[TBL] [Abstract][Full Text] [Related]
20. ABC subfamily D proteins and very long chain fatty acid metabolism as novel targets in adrenoleukodystrophy.
Morita M; Shimozawa N; Kashiwayama Y; Suzuki Y; Imanaka T
Curr Drug Targets; 2011 May; 12(5):694-706. PubMed ID: 21039332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
